NCT05144217 - Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Drug-induced Liver Injury

Interventions

DRUG

Placebo

1 capsule per day of placebo

DRUG

2x 140 mg per day

2 capsule per day of silimarit

DRUG

3x 280 mg per day

3 capsule per day of silimarit

DRUG

1x 1120 mg

8 capsule per day of silimarit

Trial Locations (2)

Universtity Hospital - clinic for dermatology, venerology and allergology, Frankfurt

CIRI, Frankfurt